New and reemerging diseases: the importance of biomedical research.
作者信息
Fauci A S
机构信息
National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Emerg Infect Dis. 1998 Jul-Sep;4(3):374-8. doi: 10.3201/eid0403.980308.
Abstract
摘要
相似文献
1
New and reemerging diseases: the importance of biomedical research.新型和再度出现的疾病：生物医学研究的重要性。
Emerg Infect Dis. 1998 Jul-Sep;4(3):374-8. doi: 10.3201/eid0403.980308.
2
Proteomics. Public-private group maps out initiatives.蛋白质组学。公私合作团体规划各项举措。
Science. 2002 May 3;296(5569):827. doi: 10.1126/science.296.5569.827.
3
Standards of ethics at the National Institutes of Health.美国国立卫生研究院的伦理标准。
N Engl J Med. 2005 Mar 31;352(13):1290-2. doi: 10.1056/NEJMp058049.
4
Public health. Public-private partnerships and scientific imperialism.公共卫生。公私伙伴关系与科学帝国主义。
Science. 2008 May 23;320(5879):1016-7. doi: 10.1126/science.1156720.
5
Human genome. Reaching their goal early, sequencing labs celebrate.人类基因组。测序实验室提前达成目标，纷纷庆祝。
Science. 2003 Apr 18;300(5618):409. doi: 10.1126/science.300.5618.409.
6
Development of vaccines to meet public health needs: incentives and obstacles.开发满足公共卫生需求的疫苗：激励因素与障碍
Risk. 1996 Summer;7(3):239-52.
7
New ethical requirements at the NIH: implications for CIHR and Canada.美国国立卫生研究院的新伦理要求：对加拿大卫生研究院及加拿大的影响。
CMAJ. 2005 Aug 16;173(4):353-4. doi: 10.1503/cmaj.050441.
8
Relations thaw between genome rivals as finish line draws near.随着终点线临近，基因组竞争对手之间的关系缓和。
Nature. 2000 Jun 15;405(6788):721. doi: 10.1038/35015744.
9
Meeting the challenge of antibiotic resistance.应对抗生素耐药性挑战。
BMJ. 2008 Sep 18;337:a1438. doi: 10.1136/bmj.a1438.
10
Industry and academia in transition.处于转型期的产业与学术界。
Science. 2003 Nov 21;302(5649):1293. doi: 10.1126/science.302.5649.1293.
引用本文的文献
1
Professional Status of Infectious Disease Specialists in Korea: A Nationwide Survey.韩国传染病专家的专业地位：一项全国性调查。
J Korean Med Sci. 2022 Dec 5;37(47):e320. doi: 10.3346/jkms.2022.37.e320.
2
Isolation of bioactive compounds from medicinal plants used in traditional medicine: Rautandiol B, a potential lead compound against Plasmodium falciparum.从传统医学中使用的药用植物中分离生物活性化合物：Rautandiol B，一种针对恶性疟原虫的潜在先导化合物。
BMC Complement Med Ther. 2021 Sep 13;21(1):231. doi: 10.1186/s12906-021-03406-y.
3
Some biological activities of Epaltes divaricata L. - an in vitro study.发散叶艾纳香的某些生物学活性——一项体外研究
Ann Clin Microbiol Antimicrob. 2015 Mar 24;14:18. doi: 10.1186/s12941-015-0074-4.
4
Ethnobotanical and antimicrobial studies of some plants used in Kibwezi (Kenya) for management of lower respiratory tract infections.肯尼亚基布韦齐用于治疗下呼吸道感染的一些植物的民族植物学和抗菌研究
Afr J Tradit Complement Altern Med. 2011;8(2):144-9. doi: 10.4314/ajtcam.v8i2.63201. Epub 2010 Dec 30.
5
Global health: chronic diseases and other emergent issues in global health.全球健康：慢性病与全球健康领域的其他新出现问题。
Infect Dis Clin North Am. 2011 Sep;25(3):623-38, ix. doi: 10.1016/j.idc.2011.05.008.
本文引用的文献
1
Update: isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, 1997-1998.最新消息：从人类身上分离出甲型禽流感病毒（H5N1）——香港，1997 - 1998年
MMWR Morb Mortal Wkly Rep. 1998 Jan 9;46(52-53):1245-7.
2
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.对万古霉素敏感性降低的金黄色葡萄球菌——美国，1997年
MMWR Morb Mortal Wkly Rep. 1997 Aug 22;46(33):765-6.
Zotero 插件